VRCA FY 2021 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

VRCAVerrica Pharmaceuticals Inc.

$57M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M

Gross Profit

$12M96.1% margin

Operating Income

-$31M-257.6% margin

Net Income

-$35M-292.3% margin

EPS (Diluted)

$-12.97

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$28M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$80M

Total Liabilities

$48M

Stockholders' Equity

$33M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$0	—
Gross Profit	$12M	-$229,000	+5134.1%
Operating Income	-$31M	-$40M	+23.1%
Net Income	-$35M	-$45M	+22.9%